GLUD2 and Cerebellar atrophy: We expect that for gain-of-function constitutively active GluD2 variants, a small molecule capable of inhibiting the constitutive inward current could reduce excitotoxity of the Purkinje cells [37] and possibly reduce cerebellar atrophy.